953 related articles for article (PubMed ID: 23669226)
1. Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers.
Jain RK
J Clin Oncol; 2013 Jun; 31(17):2205-18. PubMed ID: 23669226
[TBL] [Abstract][Full Text] [Related]
2. Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges.
Martin JD; Seano G; Jain RK
Annu Rev Physiol; 2019 Feb; 81():505-534. PubMed ID: 30742782
[TBL] [Abstract][Full Text] [Related]
3. Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside.
Stylianopoulos T; Munn LL; Jain RK
Trends Cancer; 2018 Apr; 4(4):292-319. PubMed ID: 29606314
[TBL] [Abstract][Full Text] [Related]
4. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.
Jain RK
Science; 2005 Jan; 307(5706):58-62. PubMed ID: 15637262
[TBL] [Abstract][Full Text] [Related]
5. Normalization of the vasculature for treatment of cancer and other diseases.
Goel S; Duda DG; Xu L; Munn LL; Boucher Y; Fukumura D; Jain RK
Physiol Rev; 2011 Jul; 91(3):1071-121. PubMed ID: 21742796
[TBL] [Abstract][Full Text] [Related]
6. Reengineering the Tumor Vasculature: Improving Drug Delivery and Efficacy.
Stylianopoulos T; Munn LL; Jain RK
Trends Cancer; 2018 Apr; 4(4):258-259. PubMed ID: 29606306
[TBL] [Abstract][Full Text] [Related]
7. Tumor vasculature and microenvironment normalization: a possible mechanism of antiangiogenesis therapy.
Huang G; Chen L
Cancer Biother Radiopharm; 2008 Oct; 23(5):661-7. PubMed ID: 18986217
[TBL] [Abstract][Full Text] [Related]
8. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization.
Fukumura D; Jain RK
Microvasc Res; 2007; 74(2-3):72-84. PubMed ID: 17560615
[TBL] [Abstract][Full Text] [Related]
9. Improving drug delivery to solid tumors: priming the tumor microenvironment.
Khawar IA; Kim JH; Kuh HJ
J Control Release; 2015 Mar; 201():78-89. PubMed ID: 25526702
[TBL] [Abstract][Full Text] [Related]
10. Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy.
Choi Y; Jung K
Exp Mol Med; 2023 Nov; 55(11):2308-2319. PubMed ID: 37907742
[TBL] [Abstract][Full Text] [Related]
11. Normalization of Tumor Vasculature by Oxygen Microbubbles with Ultrasound.
Ho YJ; Chu SW; Liao EC; Fan CH; Chan HL; Wei KC; Yeh CK
Theranostics; 2019; 9(24):7370-7383. PubMed ID: 31695774
[TBL] [Abstract][Full Text] [Related]
12. "Targeted plus controlled" - Composite nano delivery system opens the tumor vascular and microenvironment normalization window for anti-tumor therapy.
Shen R; Jiang Q; Li P; Wang D; Yu C; Meng T; Hu F; Yuan H
Int J Pharm; 2023 Nov; 647():123512. PubMed ID: 37839496
[TBL] [Abstract][Full Text] [Related]
13. Physical oncology: New targets for nanomedicine.
Nicolas-Boluda A; Silva AKA; Fournel S; Gazeau F
Biomaterials; 2018 Jan; 150():87-99. PubMed ID: 29035739
[TBL] [Abstract][Full Text] [Related]
14. Vascular-immuno-phenotypic (VIP) model for locally advanced and oligo-metastatic cancer: A hypothesis.
Swamy K
Med Hypotheses; 2021 Jul; 152():110618. PubMed ID: 34102599
[TBL] [Abstract][Full Text] [Related]
15. Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives.
Shang B; Cao Z; Zhou Q
Front Med; 2012 Mar; 6(1):67-78. PubMed ID: 22460450
[TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize.
Fukumura D; Jain RK
J Cell Biochem; 2007 Jul; 101(4):937-49. PubMed ID: 17171643
[TBL] [Abstract][Full Text] [Related]
17. Normalizing Tumor Vessels To Increase the Enzyme-Induced Retention and Targeting of Gold Nanoparticle for Breast Cancer Imaging and Treatment.
Xiao W; Ruan S; Yu W; Wang R; Hu C; Liu R; Gao H
Mol Pharm; 2017 Oct; 14(10):3489-3498. PubMed ID: 28845990
[TBL] [Abstract][Full Text] [Related]
18. [A concept of regulating tumor microenvironment immune and normalizing angiogenesis by Chinese medicine drug therapy for supporting zheng-qi to prop up root].
Xiong L; Tian SX
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Feb; 30(2):201-4. PubMed ID: 20462053
[TBL] [Abstract][Full Text] [Related]
19. Effect of pazopanib on tumor microenvironment and liposome delivery.
Tailor TD; Hanna G; Yarmolenko PS; Dreher MR; Betof AS; Nixon AB; Spasojevic I; Dewhirst MW
Mol Cancer Ther; 2010 Jun; 9(6):1798-808. PubMed ID: 20515941
[TBL] [Abstract][Full Text] [Related]
20. Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion.
Sorensen AG; Emblem KE; Polaskova P; Jennings D; Kim H; Ancukiewicz M; Wang M; Wen PY; Ivy P; Batchelor TT; Jain RK
Cancer Res; 2012 Jan; 72(2):402-7. PubMed ID: 22127927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
